Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Filatova

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 28, 2020
[Migraine burden and clinical inertia: what can we do?]M V Naprienko, N V Latysheva, A R Artemenko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 20, 2019
[Real-world migraine burden: clinical and economic aspects]M V Naprienko, L V Smekalkina, M I Safonov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 30, 2015
[Computerized method of objectification of dizziness and vertigo and differential diagnostic of vestibulopathies]L N Kornilova, G A Ekimovskiy, E V Habarova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 25, 2018
[Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts)]G R Tabeeva, A V Amelin, L R Akhmadeeva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 14, 2023
[Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial]A R Artemenko, V G Abramov, Z N Konovalova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 23, 2023
[Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial]A R Artemenko, V G Abramov, T V Bozhenkina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 18, 2017
[Diagnosis and treatment of migraine: Recommendations of the Russian experts]V V Osipova, E G Filatova, A R Artemenko, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 28, 2020
[Migraine burden and clinical inertia: what can we do?]M V Naprienko, N V Latysheva, A R Artemenko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 20, 2019
[Real-world migraine burden: clinical and economic aspects]M V Naprienko, L V Smekalkina, M I Safonov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 30, 2015
[Computerized method of objectification of dizziness and vertigo and differential diagnostic of vestibulopathies]L N Kornilova, G A Ekimovskiy, E V Habarova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 25, 2018
[Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts)]G R Tabeeva, A V Amelin, L R Akhmadeeva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 14, 2023
[Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial]A R Artemenko, V G Abramov, Z N Konovalova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 23, 2023
[Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial]A R Artemenko, V G Abramov, T V Bozhenkina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 18, 2017
[Diagnosis and treatment of migraine: Recommendations of the Russian experts]V V Osipova, E G Filatova, A R Artemenko, et al.
Pageof 5